Navigation Links
General tumor marker test now offered by GenWay clinical laboratory
Date:8/21/2009

(San Diego, CA) August 21, 2009 GenWay Clinical Laboratory, a US-based diagnostic company with CLIA certification, has validated a general tumor marker test in their laboratory and now offers this testing service. This is an ELISA-based assay which simply requires a small blood sample from the patient in order to quantify the amount of the tumor marker in their serum. This unique and proprietary test formula detects and quantifies specific biomarkers, tumor fibrin and fibrinogen degradation products (tFFDP), which are by-products of cancer cells. Elevated tFFDP levels have been associated with at least 14 different cancer types including lung, breast, stomach, liver, colon, rectal, ovarian, esophageal, cervical, trophoblastic, thyroid, malignant lymphoma, brain and pancreatic cancer making it one of the most versatile cancer biomarkers available. GenWay is continuing to evaluate the use of this test in other applications. This general tumor marker test can identify elevated levels of tFFDP in a patient which could potentially correspond to the presence of a malignant tumor.


'/>"/>

Contact: Jill Dombrauckas, Ph.D.
jdom@genwaybio.com
GenWay Biotech
Source:Eurekalert

Page: 1

Related biology news :

1. American Society for Microbiology to host 109th general meeting in Philadelphia
2. Journal of General Physiology explores mysteries of TRP channels in latest Perspectives series
3. Mass. Generals Warren Triennial Prize honors discoverers of microRNAs
4. March of Dimes announces Prematurity Campaign expansion at Surgeon Generals conference
5. Mass. General study shows how exercise changes structure and function of heart
6. American Society for Microbiology 108th General Meeting
7. Remarks Prepared for Delivery By Attorney General Michael B. Mukasey At the Ministerial Press Conference
8. In nature -- and maybe the corner office -- scientists find that generalists can thrive
9. Generalist bacteria discovered in coastal waters may be more flexible than known before
10. Society for General Microbiology 161st Meeting, University of Edinburgh
11. Tumor suppressor pulls double shift as reprogramming watchdog
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, has ... The bold new look is part of a transformation to increase awareness, appeal to ... period. , It will also expand its service offering from its signature gourmet cooking ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
Breaking Biology Technology: